Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

50%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Detailed Status

Completed2

Recruiting1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (33.3%)

N/A2 (66.7%)

Trials by Status

completed250%

recruiting125%

active_not_recruiting125%

Recent Activity

2 active trials

Showing 4 of 4

recruitingnot_applicable

Mentor Moms+ Study

NCT06962592

active_not_recruitingphase_2

Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

NCT04464980

completed

Validation of the "TASQ" in Patients Undergoing SAVR or TF-TAVI

NCT03186339

completednot_applicable

Minimal Invasive Laser Hemorrhoidoplasty vs Conventional Excisional Hemorrhoidectomy in II-III Grade Hemorrhoidal Disease

NCT04944407

Clinical Trials (4)

Showing 4 of 4 trials

NCT06962592Not Applicable

Mentor Moms+ Study

Recruiting

NCT04464980Phase 2

Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

Active Not Recruiting

NCT03186339

Validation of the "TASQ" in Patients Undergoing SAVR or TF-TAVI

Completed

NCT04944407Not Applicable

Minimal Invasive Laser Hemorrhoidoplasty vs Conventional Excisional Hemorrhoidectomy in II-III Grade Hemorrhoidal Disease

Completed

All 4 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 4